ZA884186B - Transdermal delivery of pharmaceuticals - Google Patents

Transdermal delivery of pharmaceuticals

Info

Publication number
ZA884186B
ZA884186B ZA884186A ZA884186A ZA884186B ZA 884186 B ZA884186 B ZA 884186B ZA 884186 A ZA884186 A ZA 884186A ZA 884186 A ZA884186 A ZA 884186A ZA 884186 B ZA884186 B ZA 884186B
Authority
ZA
South Africa
Prior art keywords
transdermal delivery
pharmaceuticals
enantiomers
mixtures
compositions
Prior art date
Application number
ZA884186A
Other languages
English (en)
Inventor
John Michael Pawelchak
Michael Pawelchak John
James Ronald Lawter
Ronald Lawter James
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA884186B publication Critical patent/ZA884186B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA884186A 1987-06-12 1988-06-10 Transdermal delivery of pharmaceuticals ZA884186B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6184287A 1987-06-12 1987-06-12

Publications (1)

Publication Number Publication Date
ZA884186B true ZA884186B (en) 1989-03-29

Family

ID=22038497

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884186A ZA884186B (en) 1987-06-12 1988-06-10 Transdermal delivery of pharmaceuticals

Country Status (16)

Country Link
EP (1) EP0294601B1 (ja)
JP (1) JP2654092B2 (ja)
KR (1) KR970000506B1 (ja)
AT (1) ATE84714T1 (ja)
AU (1) AU609142B2 (ja)
CA (1) CA1305418C (ja)
DE (1) DE3877630T2 (ja)
DK (1) DK171746B1 (ja)
ES (1) ES2043719T3 (ja)
GR (1) GR3006938T3 (ja)
IE (1) IE62735B1 (ja)
IL (1) IL86334A (ja)
NO (1) NO178096C (ja)
NZ (1) NZ224891A (ja)
PT (1) PT87704B (ja)
ZA (1) ZA884186B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
US5476854A (en) * 1991-11-27 1995-12-19 Sepracor Inc. Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
JPH08503465A (ja) * 1992-11-09 1996-04-16 ファーメトリックス コーポレイション ケトロラックの経皮デリバリー
EP1406633B1 (en) 2001-06-18 2011-10-05 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
EP1628663B1 (en) 2003-05-15 2009-07-29 Roskamp Research llc Method for producing medicaments for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
DK2214666T3 (da) 2007-10-05 2014-01-27 Alzheimer S Inst Of America Inc Fremgangsmåde til reducering af amyloid-afsætning, amyloid-neurotoksicitet og mikrogliose med (-)-nilvadipin-enantiomer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
JPS60258179A (ja) * 1984-06-04 1985-12-20 Yamanouchi Pharmaceut Co Ltd Ｙｍ−０９７３０のジアステレオマ−ａの右旋性光学異性体またはその酸付加塩，該化合物の製造方法および該化合物からなる医薬
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JP2654092B2 (ja) 1997-09-17
CA1305418C (en) 1992-07-21
NO178096C (no) 1996-01-24
IL86334A (en) 1992-09-06
ES2043719T3 (es) 1994-01-01
ATE84714T1 (de) 1993-02-15
PT87704B (pt) 1993-03-31
EP0294601B1 (en) 1993-01-20
DE3877630D1 (de) 1993-03-04
PT87704A (pt) 1988-07-01
KR890000090A (ko) 1989-03-11
NZ224891A (en) 1992-06-25
DK316788A (da) 1988-12-13
DE3877630T2 (de) 1993-06-03
DK171746B1 (da) 1997-05-05
EP0294601A2 (en) 1988-12-14
IE881749L (en) 1988-12-12
AU609142B2 (en) 1991-04-26
IE62735B1 (en) 1995-02-22
DK316788D0 (da) 1988-06-10
AU1761088A (en) 1988-12-15
EP0294601A3 (en) 1989-10-11
NO178096B (no) 1995-10-16
JPS6413024A (en) 1989-01-17
KR970000506B1 (ko) 1997-01-13
GR3006938T3 (ja) 1993-06-30
NO882559D0 (no) 1988-06-10
NO882559L (no) 1988-12-13

Similar Documents

Publication Publication Date Title
DE3865817D1 (ja)
AU625830B2 (en) Transdermal delivery system
IL105715A0 (en) 7beta substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions containing them
IL105717A0 (en) 7beta substituted-4-aza-5alpha-cholestan-3-ones and pharmaceutical compositions containing them
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
GR850507B (ja)
IL80900A (en) Pharmaceutical composition containing fibrinolytic compounds and carbacyclin analogues for treatment of thrombosis
ZA884186B (en) Transdermal delivery of pharmaceuticals
ZA884418B (en) Pharmaceutical dosage unit
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
GR3001277T3 (en) Chlorpheniramine therapy
TW218011B (ja)
MY102026A (en) Antiasthmatic.
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
ATE81971T1 (de) Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.
AU575067B2 (en) Salts of l or (s)-3-(3,4-dihydroxyphenyl)-2- methylalanine esters
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents